{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:49:31Z","timestamp":1758440971232,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.medcli.2019.03.036","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T20:25:35Z","timestamp":1561494335000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Registro espa\u00f1ol de la enfermedad de Pompe: an\u00e1lisis de los primeros 49 pacientes con enfermedad de Pompe del adulto"],"prefix":"10.1016","volume":"154","author":[{"given":"Jorge","family":"Alonso-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Mendoza Grim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Fern\u00e1ndez-Torr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"L\u00f3pez de Munain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Mu\u00f1oz-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Ramos-Fransi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Almendrote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Illa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"D\u00edaz-Manera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.03.036_bib0160","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"Van der Ploeg","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2019.03.036_bib0165","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: From basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.medcli.2019.03.036_bib0170","first-page":"S4","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.03.036_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur J Hum Genet."},{"key":"10.1016\/j.medcli.2019.03.036_bib0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: Implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur J Hum Genet."},{"key":"10.1016\/j.medcli.2019.03.036_bib0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.medcli.2019.03.036_bib0190","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1542\/peds.2016-0280C","article-title":"Newborn screening for Pompe disease","volume":"140","author":"Bodamer","year":"2017","journal-title":"Pediatrics."},{"key":"10.1016\/j.medcli.2019.03.036_bib0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr."},{"key":"10.1016\/j.medcli.2019.03.036_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: Clinical spectrum and genotype in 31 patients","volume":"11","author":"Van Capelle","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.medcli.2019.03.036_bib0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.c.31322","article-title":"Toward deconstructing the phenotype of late-onset Pompe disease","volume":"160C","author":"Schuller","year":"2012","journal-title":"Am J Med Genet C."},{"key":"10.1016\/j.medcli.2019.03.036_bib0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience","volume":"160","author":"Bali","year":"2012","journal-title":"Am J Med Genet Part C."},{"key":"10.1016\/j.medcli.2019.03.036_bib0215","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neurol.2013.07.002","article-title":"The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease","volume":"169","author":"Lafor\u00eat","year":"2013","journal-title":"Rev Neurol (Par\u00eds)."},{"key":"10.1016\/j.medcli.2019.03.036_bib0220","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"Van der Ploeg","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2019.03.036_bib0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid \u03b1-glucosidase: Major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.03.036_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0771-0","article-title":"Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy","volume":"13","author":"Parini","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.medcli.2019.03.036_bib0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.medcli.2019.03.036_bib0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2017.04.014","article-title":"Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up","volume":"121","author":"Spiridigliozzi","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2019.03.036_bib0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: A systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2019.03.036_bib0250","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease: A 5-year prospective study","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.03.036_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0889-0","article-title":"Eight years after an international workshop on myotonic dystrophy patient registries: Case study of a global collaboration for a rare disease","volume":"13","author":"Wood","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.medcli.2019.03.036_bib0260","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","article-title":"Myasthenia gravis: Descriptive analysis of life-threatening events in a recent nationwide registry","volume":"22","author":"Ramos-Fransi","year":"2015","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.medcli.2019.03.036_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06894-6","article-title":"Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain","volume":"7","author":"Sivera","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.medcli.2019.03.036_bib0270","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/s41598-018-38025-0","article-title":"PDGF-BB serum levels are decreased in adult onset Pompe patients","volume":"9","author":"Fern\u00e1ndez-Sim\u00f3n","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.medcli.2019.03.036_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1751-0473-8-21","article-title":"Dispelling myths about rare disease registry system development","volume":"8","author":"Bellgard","year":"2013","journal-title":"Source Code Biol Med."},{"key":"10.1016\/j.medcli.2019.03.036_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-29170-7","article-title":"Quantitative muscle MRI to follow up late onset Pompe patients: A prospective study","volume":"8","author":"Figueroa-Bonaparte","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.medcli.2019.03.036_bib0285","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: A prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2019.03.036_bib0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2017.09.008","article-title":"HHS public access","volume":"122","author":"Rairikar","year":"2017","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.medcli.2019.03.036_bib0295","doi-asserted-by":"crossref","first-page":"e0163493","DOI":"10.1371\/journal.pone.0163493","article-title":"Muscle MRI findings in childhood\/adult onset Pompe disease correlate with muscle function","volume":"11","author":"Figueroa-Bonaparte","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2019.03.036_bib0300","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2019.03.036_bib0305","first-page":"82","article-title":"Pompe disease (glycogen storage disease type II): Clinical features and enzyme replacement therapy","volume":"106","author":"Van der Beek","year":"2006","journal-title":"Acta Neurol Belg."},{"key":"10.1016\/j.medcli.2019.03.036_bib0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nmd.2016.10.010","article-title":"Quantification of muscle pathology in infantile Pompe disease","volume":"27","author":"Sch\u00e4nzer","year":"2017","journal-title":"Neuromuscul Disord."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531930346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531930346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:49:54Z","timestamp":1758419394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577531930346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S002577531930346X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.03.036","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Registro espa\u00f1ol de la enfermedad de Pompe: an\u00e1lisis de los primeros 49 pacientes con enfermedad de Pompe del adulto","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}